Clinical trials of alteplase

Clinical trials of alteplase and meta-analysis are available for the following clinical conditions:

acute myocardial infarction

acute myocardial infarction, myocardial revascularization, facilated PCI

alteplase vs primary intervention : LIMI (Vermeer), 1999 - PACT (Ross,), 1999 -

Entry terms: Plasminogen Activator, Tissue, Tissue Plasminogen Activator, Plasminogen Activator, Tissue, Tissue Activator D-44, Tissue Activator D 44, Tisokinase, Tissue-Type Plasminogen Activator, Tissue Type Plasminogen Activator, TTPA, T-Plasminogen Activator, T Plasminogen Activator, Alteplase, Plasminogen Activator, Tissue-Type, Plasminogen Activator, Tissue Type, Activase, Hoffmann-La Roche Brand of Alteplase, Hoffmann La Roche Brand of Alteplase, Genentech Brand of Alteplase, Alteplase Genentech Brand, Actilyse, Boehringer Ingelheim Brand of Alteplase, Lysatec rt-PA, Lysatec rt PA, Lysatec rtPA, Promeco Brand of Alteplase, Alteplase Promeco Brand, PLAT protein, human, receptor, tissue plasminogen activator, human, TTPA receptor, human, alteplase protein, human, t-PA-PAI-1 receptor, human

See also relatic topics:

Search alteplase clinical trials in Pubmed

Search alteplase clinical trials in ClinicalTrials.gov

Search alteplase clinical trials in Wikipedia

Search alteplase in drugs.com

browse_trt3

This site complies to the HONcode standard for trustworthy health information: verify here.

Last uptaded on 2010/7
61 user(s) connected

TrialResults-center database by TrialResults-center is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License .

OpenSearch feed - Add TrialResults-center.org to your browser's search bar